Skip to main content
. Author manuscript; available in PMC: 2016 Sep 19.
Published in final edited form as: Radiother Oncol. 2015 Jul 8;116(1):149–155. doi: 10.1016/j.radonc.2015.06.018

Table 4.

Factors Associated with Effectiveness by 12 Months

Variable Category 12 month denominator Do not maintain or return to pre-RT size at 12 months Maintain or return to pre-RT size at 12 months P value
Disease group 1 Rectal 15 3 (20%) 12 (80%) 0.05
2 Anal 29 9 (31%) 20 (69%)
3 Endometrial 36 3 (8%) 33 (92%)
Age <65 60 8 (13%) 52 (87%) 0.05
≥65 21 7 (33%) 14 (67%)
Race Non-white 21 5 (24%) 16 (76%) 0.52
White 60 10 (17%) 50 (83%)
Education Less than college degree 31 9 (29%) 22 (71%) 0.08
College degree or higher 50 6 (12%) 44 (88%)
Marital status Married 56 7 (13%) 49 (88%) 0.06
Other 25 8 (32%) 17 (68%)
Menopausal Pre 21 2 (10%) 19 (90%) 0.33
Post 60 13 (22%) 47 (78%)
Topical estrogen No 79 15 (19%) 64 (81%) 1.0
Yes 2 0 2 (100%)
Sexually active (baseline) No 34 8 (24%) 26 (76%) 0.39
Yes 47 7 (15%) 40 (85%)
Smoking history No 41 7 (17%) 34 (83%) 0.78
Yes 40 8 (20%) 32 (80%)
Comorbidities No 55 11 (20%) 44 (80%) 0.76
Yes 26 4 (15%) 22 (85%)
Radiation Pre-operative 15 3 (20%) 12 (80%) 0.28
Post-operative 41 5 (12%) 36 (88%)
RT with no surgery 25 7 (28%) 18 (72%)
RT modality EBRT 49 12 (24%) 37 (76%) 0.14
Intravaginal 32 3 (9%) 29 (91%)
No Chemotherapy No 54 14 (26%) 40 (74%) 0.02
Yes 27 1 (4%) 26 (96%)
Vaginal moisturizer (3 months) No 62 13 (21%) 49 (79%) 0.50
Yes 19 2 (11%) 17 (89%)
Vaginal moisturizer (6 months) No 60 15 (25%) 45 (75%) 0.009
Yes 21 0 21 (100%)
Vaginal moisturizer (12 months) No 58 12 (21%) 46 (79%) 0.54
Yes 23 3 (13%) 20 (87%)
Compliance rate by 6 months Mean (std) - 45% (34%) 68% (28%) 0.03
Compliance rate by 12 months Mean (std) - 39% (31%) 57% (27%) 0.05

Abbreviations: EBRT, external beam radiotherapy; RT, radiotherapy.